Research ArticleArticle
Facilitators and Barriers to Adherence in the Initiation Phase of Disease-modifying Antirheumatic Drug (DMARD) Use in Patients with Arthritis Who Recently Started Their First DMARD Treatment
Annelieke Pasma, Adriaan van ’t Spijker, Jolanda J. Luime, Margot J.M. Walter, Jan J.V. Busschbach and Johanna M.W. Hazes
The Journal of Rheumatology March 2015, 42 (3) 379-385; DOI: https://doi.org/10.3899/jrheum.140693
Annelieke Pasma
From Department of Rheumatology, Department of Psychiatry, and Section Medical Psychology and Psychotherapy, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam,
the Netherlands.
Adriaan van ’t Spijker
Jolanda J. Luime
Margot J.M. Walter
Jan J.V. Busschbach
REFERENCES
- 1.↵
- Smolen JS,
- Aletaha D,
- Bijlsma JW,
- Breedveld FC,
- Boumpas D,
- Burmester G,
- et al.
- 2.↵
- 3.↵
- 4.↵
- Schipper LG,
- van Hulst LT,
- Grol R,
- van Riel PL,
- Hulscher ME,
- Fransen J
- 5.↵
- 6.↵
- 7.↵
- 8.↵
- Urquhart J,
- Vrijens B
- 9.↵
- 10.↵
- Garcia Popa-Lisseanu MG,
- Greisinger A,
- Richardson M,
- O’Malley KJ,
- Janssen NM,
- Marcus DM,
- et al.
- 11.↵
- 12.↵
- Salt E,
- Peden A
- 13.↵
- Kumar K,
- Gordon C,
- Barry R,
- Shaw K,
- Horne R,
- Raza K
- 14.↵
- Goodacre LJ,
- Goodacre JA
- 15.↵
- 16.↵
- 17.↵
- 18.↵
- Townsend A,
- Backman CL,
- Adam P,
- Li LC
- 19.↵
- van der Elst K,
- Meyfroidt S,
- de Groef A,
- Binnard E,
- de Cock D,
- Moons P,
- et al.
- 20.↵
- Krueger RA,
- Casey MA
- 21.↵
- 22.↵
- 23.↵
- 24.↵
- 25.↵
- Petrie KJ,
- Cameron LD,
- Ellis CJ,
- Buick D,
- Weinman J
- 26.↵
- Bartholomew LK,
- Parcel GS,
- Kok G
- 27.↵
- Kok GJ,
- De Vries H,
- Mudde AN,
- Strecher VJ
In this issue
The Journal of Rheumatology
Vol. 42, Issue 3
1 Mar 2015
Facilitators and Barriers to Adherence in the Initiation Phase of Disease-modifying Antirheumatic Drug (DMARD) Use in Patients with Arthritis Who Recently Started Their First DMARD Treatment
Annelieke Pasma, Adriaan van ’t Spijker, Jolanda J. Luime, Margot J.M. Walter, Jan J.V. Busschbach, Johanna M.W. Hazes
The Journal of Rheumatology Mar 2015, 42 (3) 379-385; DOI: 10.3899/jrheum.140693
Facilitators and Barriers to Adherence in the Initiation Phase of Disease-modifying Antirheumatic Drug (DMARD) Use in Patients with Arthritis Who Recently Started Their First DMARD Treatment
Annelieke Pasma, Adriaan van ’t Spijker, Jolanda J. Luime, Margot J.M. Walter, Jan J.V. Busschbach, Johanna M.W. Hazes
The Journal of Rheumatology Mar 2015, 42 (3) 379-385; DOI: 10.3899/jrheum.140693